Document is current
Any future updates will be listed below
-
Authors
Wilf-Yarkoni, A. http://orcid.org/0000-0002-2584-5793
Elkayam, O.
Aizenstein, O.
Oron, Y.
Furer, V.
Zur, D.
Goldstein, M.
Barequet, D.
Hallevi, H.
Karni, A.
Habot-Wilner, Z.
Regev, K.
- License Information
-
More Information
Article History
Received: 25 May 2020
Accepted: 18 August 2020
First Online: 2 September 2020
Ethics approval and consent to participate
: The study was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments. The study was approved by the Tel Aviv Sourasky Medical Center Institutional Review Board (Helsinki Committee). (0435-15-TLV). The need for consent was waived by the IRB due to the retrospective nature of the study.
: Not applicable.
: The authors declare that they have no competing interest. None of the authors reports conflicts of interest related to this work. Dr. Karni Arnon received research support from Stem Cell Medicine Ltd., Medison Pharma Ltd. and from Novartis Pharmaceutical Ltd.
